Copyright
©2014 Baishideng Publishing Group Inc.
World J Radiol. Jul 28, 2014; 6(7): 424-436
Published online Jul 28, 2014. doi: 10.4329/wjr.v6.i7.424
Published online Jul 28, 2014. doi: 10.4329/wjr.v6.i7.424
Type ofcomplication | Prevalence in adultOLT patients | Risk factors | Time of onsetfrom OLT | Clinical features | Treatment |
Bile leak | 7.8% OLT 9.5% LDLT | T-tube displacement or removal (T-tube leak) technical failure during surgery (anastomotic leak) HAT (nonanastomotic leak) Ischemic-related injury, immunologically-related injury, cytotoxic injury induced by bile salts (nonanastomotic leak in pts. without HAT) | 1-3 mo | Fever, abdominal complaint, signs of cholestasis and or cholangitis | Leaving the T-tube open (T-Tube leaks) ERC with Sphincterotomy and stent placement Percutaneous drainage |
Anastomotic stricture | 13% OLT 19% LDLT | Older donor age Roux-en-Y choledochojejunostomy Technical factors (earlier manifestation) Ischemia of the donor bile duct (earlier manifestation) Previous anastomotic leakage (late manifestation) | within 6 mo-1 yr, occasionally later | Biliary obstruction | Surgical revision (repair or conversion to bilio-enteric anastomosis) ERC with balloon dilatation and stent placement (usually repeated procedures) Surgical revision (conversion to bilio-enteric anastomosis) |
NAS | 5%-25% | HAT Microangiopathic injury (prolonged warm or cold ischemia times of the graft) (ITBL) Immunogenic injury (AB0 incompatibility between donor and recipient, chronic ductopenic rejection, primitive sclerosing cholangitis) (ITBL) Cytotoxic injury by bile salts (ITBL) | Within 6 mo (HAT-associated NAS) After 6 mo (ITBL) | Cholestasis with recurrent cholangitis | Biliary toilette, dilatation ± stent placement via ERC/PTC Medical therapy (ursodeoxycholic acid and antibiotics if recurrent cholangitis) |
Stones, casts and sludge | 5.70% | Anastomotic and nonanastomotic biliary strictures Presence of T-tube or stent Hepaticojejunostomy Ischemia Infectious alteration in bile composition | Within 1 yr (casts and sludge) After 1 yr (stones) | Biliary obstruction | Conversion to hepaticojejunostomy(rarely) Retransplantation Bile ducts toilette using ERC/PTC Medical therapy with ursodeoxycholic acid Retransplantation |
Sphincter of Oddi dysfunction and papillary stenosis | 2%-7% | Denervation of the recipient common bile duct leading to sphincter of Oddi spasm Inflammation and/or scarring of the sphincter of Oddi | 6 mo to 1 yr | Increased cholestatic enzymes | Endoscopic sphincterotomy |
Jorgensen et al[1] | Xu et al[55] | ||
Goal | Biliary obstruction | All biliary complications | Subset of strictures |
Pooled sensitivity | 96.0% (0.92%-0.98%) | 0.95% (0.92%-0.97%) | 0.94% (0.88%-0.98%) |
Pooled specificity | 0.94% (0.90%-0.97%) | 0.92% (0.89%-0.94%) | 0.95% (0.88%-0.99%) |
AUC | 0.99 | 0.97 | 0.97 |
Pooled PLR | 17.00 (9.4-29.6) | 10.23 (6.21-16.84) | 9.96 (2.52-39.36) |
Pooled NLR | 0.04 (0.02-0.08) | 0.08 (0.06-0.12) | 0.09 (0.04-0.17) |
- Citation: Girometti R, Cereser L, Bazzocchi M, Zuiani C. Magnetic resonance cholangiography in the assessment and management of biliary complications after OLT. World J Radiol 2014; 6(7): 424-436
- URL: https://www.wjgnet.com/1949-8470/full/v6/i7/424.htm
- DOI: https://dx.doi.org/10.4329/wjr.v6.i7.424